SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950123-18-010601
Filing Date
2018-11-07
Accepted
2018-11-06 20:20:54
Documents
63
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K arct6k.htm 6-K 29665
2 EX-99.1 arctex991.htm EX-99 1001371
3 EX-99.2 arct-ex992_7.htm EX-99 276379
4 EX-99.3 arct-ex993_90.htm EX-99 335773
  Complete submission text file 0000950123-18-010601.txt   5913180

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arct-20180930.xml EX-101.INS 1274713
6 XBRL TAXONOMY EXTENSION SCHEMA arct-20180930.xsd EX-101.SCH 45365
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arct-20180930_cal.xml EX-101.CAL 41270
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arct-20180930_def.xml EX-101.DEF 129653
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arct-20180930_lab.xml EX-101.LAB 337329
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arct-20180930_pre.xml EX-101.PRE 261615
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-900-2660
Arcturus Therapeutics Ltd. (Filer) CIK: 0001566049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35932 | Film No.: 181164494
SIC: 2834 Pharmaceutical Preparations